The genetic heterogeneity of AML can also translate into complex expression profiles for various cell-surface markers38 including the Fc-gamma receptors (FcγRs) CD16, CD32 and CD64 (ref. 39). The gene discussed is FCGR3A; the disease is acute myeloid leukemia.